Tadataka Yamada's Net Worth
$5.71 Million
Who is Tadataka Yamada?
Tadataka Yamada has an estimated net worth of $5.71 Million. This is based on reported shares across multiple companies, which include AGILENT TECHNOLOGIES INC, Covidien Ltd., Prometheus Biosciences, Inc., Icosavax, Inc., Phathom Pharmaceuticals, Inc., Athira Pharma, Inc., and Passage BIO, Inc..
SEC CIK
Tadataka Yamada's CIK is 0001402530
Past Insider Trading and Trends
2020 was Tadataka Yamada's most active year for acquiring shares with 7 total transactions. Tadataka Yamada's most active month to acquire stocks was the month of February. 2011 was Tadataka Yamada's most active year for disposing of shares, totalling 2 transactions. Tadataka Yamada's most active month to dispose stocks was the month of February. 2019 saw Tadataka Yamada paying a total of $354,965.21 for 4,328.844 shares, this is the most they've acquired in one year. In 2011 Tadataka Yamada cashed out on 2,274 shares for a total of $116,178.66, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AGILENT TECHNOLOGIES, INC. (A) Snapshot price: $137.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.36% | 212 |
$93.91 | $19,908.92 | 58.37K |
Aug 3
| |||
Form 4
| +8.04% | 4.31K |
$73.01 | $314,887.82 | 57.98K |
Apr 17
| |||
Form 4
| +8.84% | 4.33K |
$82.00 | $354,965.21 | 53.31K |
Mar 21
| |||
Form 4
| +10.45% | 4.6K |
$67.47 | $310,475.08 | 48.65K |
Mar 22
| |||
Form 4
| +16.46% | 6.19K |
$53.05 | $328,158.12 | 43.78K |
Mar 16
| |||
Form 4
| +23.31% | 7.06K |
$39.29 | $277,243.05 | 37.33K |
Mar 17
| |||
Form 4
| +27.38% | 6.47K |
$42.21 | $272,958.94 | 30.09K |
Mar 19
| |||
Form 4
| +32.42% | 4.74K |
$56.69 | $268,553.23 | 19.35K |
Mar 20
| |||
Form 4
| +77.98% | 6.38K |
$41.65 | $265,524.91 | 14.55K |
Mar 21
| |||
Form 4
| +99.58% | 4.08K |
$43.71 | $178,293.09 | 8.18K |
Mar 22
| |||
Form 4
| +758.70% | 3.62K |
$41.46 | $150,043.74 | 4.1K |
Mar 2
| |||
Form 4
|
∞
| 477 |
$42.97 | $20,496.69 | 477 |
Jan 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Covidien plc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.21% | 368 |
$51.09 | -$116,178.66 | 11.83K |
Mar 15
| |||
Form 4
| +0.10% | 11 |
—
|
—
| 11.46K |
Feb 22
| |||
Form 4
| +0.11% | 13 |
—
|
—
| 11.45K |
Nov 8
| |||
Form 4
| +0.11% | 13 |
—
|
—
| 11.44K |
Aug 20
| |||
Form 4
| +0.09% | 10 |
—
|
—
| 11.43K |
May 14
| |||
Form 4
| +30.70% | 2.68K |
—
|
—
| 11.41K |
Mar 16
| |||
Form 4
| +0.16% | 14 |
—
|
—
| 8.73K |
Feb 23
| |||
Form 4
| +0.18% | 16 |
—
|
—
| 8.72K |
Nov 6
| |||
Form 4
| +0.17% | 15 |
—
|
—
| 8.7K |
Aug 25
| |||
Form 4
| +0.21% | 18 |
—
|
—
| 8.69K |
May 4
| |||
Form 4
| +78.12% | 3.8K |
—
|
—
| 8.67K |
Mar 17
| |||
Form 4
| +129.15% | 2.72K |
—
|
—
| 4.83K |
Mar 18
| |||
Form 4
| +0.38% | 8 |
—
|
—
| 2.11K |
Feb 11
| |||
Form 4
| +0.38% | 8 |
—
|
—
| 2.1K |
Nov 9
| |||
Form 4
|
∞
| 2.09K |
—
|
—
| 2.09K |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prometheus Biosciences, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 13.33K |
—
|
—
| 13.33K |
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Icosavax, Inc. (ICVX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Phathom Pharmaceuticals, Inc. (PHAT) Snapshot price: $17.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||